This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Researchers have identified a new candidate tumor suppressor gene in colorectal cancer and examinedits use as a potential biomarker in stool samples, according to a new study published online June 17 in the Journal of the National Cancer Institute. In the study, Manon van Engeland, Ph.D., of the Department of Pathology at Maastricht University Medical Center in the Netherlands, and colleagues examined N-Myc downstream-regulated gene 4 (NDRG4) as a novel tumor suppressor and biomarker.
We care about your feedback. Let us know how we can improve your CancerCompass experience.